Discontinuation syndrome following cessation of treatment with clonidine and other antihypertensive agents.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003000:Clonidine / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004338:Drug Combinations; D003000:Clonidine